Annual Cash & Cash Equivalents
$344.07M$15.22M-4.24%
Summary
- Current Value
- As of today, TXG annual cash & cash equivalents is $344.07M, down -4.24% on
- Historical Performance
- TXG annual cash & cash equivalents is down -41.43% over the past 3 years, and down -18.88% over the past 5 years
- All-Time High Comparison
- TXG annual cash & cash equivalents is currently -48.15% below its historical high of $663.60M set on
- 3-Year Low Comparison
- TXG annual cash & cash equivalents is +56.57% above its 3-year low of $219.75M reached on an earlier date
- Sector Comparison
- TXG annual cash & cash equivalents is higher than 85.69% of companies in Healthcare sector
Cash and Cash Equivalents Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual Cash & Cash Equivalents | $344.07M | -4.2% | -41.4% | -18.9% | +619.0% | |
| Quarterly Cash & Cash Equivalents | $482.08M | +21.1% | +6.5% | -41.8% | +29.2% | |
| Price | $19.99 | +28.7% | -47.1% | -87.4% | – | |
| Annual Current Assets | $584.39M | -1.9% | -21.8% | +21.5% | +758.0% | |
| Annual Total Liabilities | $208.50M | -7.0% | +3.6% | – | +10.8% | |
| Annual Working Capital | $466.75M | -0.5% | -26.8% | +11.7% | +915.4% | |
| Annual Net Income | -$182.63M | +28.4% | -213.7% | -484.4% | -873.4% |
Cash and Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $359.28M | -4.2% | |
| 5Y | $663.60M | N/A | -48.1% |
| All | $663.60M | -48.1% |
Cash and Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $219.75M | N/A | +56.6% |
| 5Y | $219.75M | +56.6% | |
| All | $47.86M | +619.0% |
Cash and Cash Equivalents History
| Year | Value | Change |
|---|---|---|
| $344.07M | -4.2% | |
| $359.28M | +63.5% | |
| $219.75M | -62.6% | |
| $587.45M | -11.5% |
| Year | Value | Change |
|---|---|---|
| $663.60M | +56.4% | |
| $424.17M | +551.8% | |
| $65.08M | +36.0% | |
| $47.86M | - |
FAQ
What is the current annual cash & cash equivalents of TXG?
As of today, TXG annual cash & cash equivalents is $344.07M
What is 1-year change in TXG annual cash & cash equivalents?
TXG annual cash & cash equivalents is down -4.24% year-over-year
What is 3-year change in TXG annual cash & cash equivalents?
TXG annual cash & cash equivalents is down -41.43% over the past 3 years
How far is TXG annual cash & cash equivalents from its all-time high?
TXG annual cash & cash equivalents is currently -48.15% below its historical high of $663.60M set on December 31, 2020
How does TXG annual cash & cash equivalents rank versus sector peers?
TXG annual cash & cash equivalents is higher than 85.69% of companies in Healthcare sector
When is TXG next annual earnings release?
The next annual earnings release for TXG is on
Quarterly Cash & Cash Equivalents
$482.08M$34.82M+7.79%
Summary
- Current Value
- As of today, TXG quarterly cash & cash equivalents is $482.08M, up +7.79% on
- Historical Performance
- TXG quarterly cash & cash equivalents is up +21.08% year-over-year, and up +6.45% over the past 3 years
- All-Time High Comparison
- TXG quarterly cash & cash equivalents is currently -41.79% below its historical high of $828.22M set on
- 3-Year Low Comparison
- TXG quarterly cash & cash equivalents is +34.88% above its 3-year low of $357.41M reached on
- Sector Comparison
- TXG quarterly cash & cash equivalents is higher than 85.34% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly Cash & Cash Equivalents | $482.08M | +7.8% | +21.1% | +6.5% | -41.8% | |
| Annual Cash & Cash Equivalents | $344.07M | – | -4.2% | -41.4% | -18.9% | |
| Price | $19.99 | +72.3% | +28.7% | -47.1% | -87.4% | |
| Quarterly Current Assets | $659.83M | +0.6% | +11.1% | +4.8% | -26.7% | |
| Quarterly Total Liabilities | $242.24M | +17.2% | +12.7% | +9.9% | +11.4% | |
| Quarterly Working Capital | $512.50M | -5.7% | +8.4% | +2.0% | -32.1% | |
| Quarterly Net Income | -$27.47M | -179.5% | +23.2% | +34.5% | +58.3% |
Quarterly Cash & Cash Equivalents Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $482.08M | at high | |
| 3Y | $482.08M | at high | |
| 5Y | $680.17M | N/A | -29.1% |
| All | $828.22M | -41.8% |
Quarterly Cash & Cash Equivalents Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $393.40M | N/A | +22.5% |
| 3Y | $357.41M | +34.9% | |
| 5Y | $357.41M | +34.9% | |
| All | $46.77M | +930.8% |
Quarterly Cash & Cash Equivalents History
FAQ
What is the current quarterly cash & cash equivalents of TXG?
As of today, TXG quarterly cash & cash equivalents is $482.08M
What is TXG quarterly cash & cash equivalents most recent change?
TXG quarterly cash & cash equivalents was up +7.79% on September 30, 2025
What is 1-year change in TXG quarterly cash & cash equivalents?
TXG quarterly cash & cash equivalents is up +21.08% year-over-year
How far is TXG quarterly cash & cash equivalents from its all-time high?
TXG quarterly cash & cash equivalents is currently -41.79% below its historical high of $828.22M set on September 30, 2020
How does TXG quarterly cash & cash equivalents rank versus sector peers?
TXG quarterly cash & cash equivalents is higher than 85.34% of companies in Healthcare sector
When is TXG next earnings release?
The next earnings release for TXG is on
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
Data Sources & References
- TXG Official Website www.10xgenomics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1770787/000162828025050332/0001628280-25-050332-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1770787/000177078725000013/0001770787-25-000013-index.htm
- TXG Profile on Yahoo Finance finance.yahoo.com/quote/TXG
- TXG Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/txg